Rate My Professor Oliver Rawashdeh

Rawashdeh's research program bridges neuroscience and circadian biology, investigating how endogenous biological clocks regulate sleep, learning, memory, and homeostasis, with particular emphasis on disruptions in neurodegenerative conditions such as Parkinson’s disease, Alzheimer’s disease, and other synucleinopathies. His studies encompass clock gene-mediated photic signaling, melatonin’s influence on memory consolidation, mathematical modeling of circadian networks, and chronotherapeutic strategies. He has been awarded NHMRC IDEAS Grants spanning 2020 to 2024 to explore the circadian clock as a therapeutic target for improving sleep and combating chronodegeneration in Parkinson’s disease. Prominent publications feature “Melatonin suppresses nighttime memory formation in zebrafish” (Science, 2007), “Circadian modulation of complex learning in diurnal and nocturnal Aplysia” (Proceedings of the National Academy of Sciences, 2005), “Learned motivation drives circadian physiology in the absence of the master circadian clock” (FASEB Journal, 2017), “Cholinergic basal forebrain degeneration due to sleep-disordered breathing exacerbates pathology in a mouse model of Alzheimer’s disease” (Nature Communications, 2022), “Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T3) supplementation” (eLife, 2022), “Sleep and circadian rhythms in α-synucleinopathies—perspectives for disease modification” (Acta Physiologica, 2023), and “Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease” (Journal of Neurology, 2023). Rawashdeh supervises doctoral students examining sleep-circadian interactions in neurodegeneration, brain injury, and related pathologies, contributing to translational advancements in chronomedicine.